Peptide Industry Leaders’ Panel Discussion – Is 2025 the Goldilocks Year for Peptide-Based Therapeutics?
Time: 8:20 am
day: Conference Day One
Details:
This panel will discuss the key breakthroughs that have happened this year, the key challenges that have been overcome, and where the biggest excitement remains:
- Taking stock of the strengths, weaknesses, opportunities and threats (SWOT) for peptide-based therapeutics
- How do you perceive the peptide therapeutics space? How has this changed in the past 12 months?
- What are the scientific bottlenecks that are slowing peptide-based drug discovery into translation and into the clinic?
- How are peptide-based therapies going to be positioned against standards of care, compete against other drugs and take market share away from small molecules, antibody drug conjugates and other biologics?
